News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Infusion-to-injection infliximab switch safe, helps lower risk of IBD relapse for some patients
24 Aug 2022
Switching from intravenous to subcutaneous infliximab appears to be safe and well-accepted, resulting in a reduced risk of relapse in some inflammatory bowel disease (IBD) patients, according to data from the REMSWITCH study.
24 Aug 2022







